Live Breaking News & Updates on Pharmacogenomics Market

Stay updated with breaking news from Pharmacogenomics market. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Pharmacogenomics: Global Market Opportunities by Technology, Service, Application, End-user, and Region to 2027

Dublin, Aug. 28, 2023 (GLOBE NEWSWIRE) The "Global Pharmacogenomics Market Size, Share, Trends, Opportunity, and Forecast to 2027" report has been added to ResearchAndMarkets.com's offering. The global pharmacogenomics market is poised for robust growth during the forecast period, driven by the increasing adoption of personalized medicine in healthcare. The rising prevalence of chronic diseases, such as cancer, cardiovascular ailments, respiratory disorders, and renal conditions, has escalate ....

United States , Pacific Biosciences , Asia Pacific , Research Development Activities , Admera Health , Research Methodology , Illumina Inc , California Inc , Israel Precision Medicine Partnership , Oxford Nanopore Technologies , Perkinelmer Inc , Agilent Technologies Inc , Abbott Laboratories Inc , Genetics Inc , Thermo Fischer Scientific Inc , National Institute Of Health , Bio Rad Laboratories Inc , Pharmacogenomics Market Size , Infosys Limited , Adverse Drug Reactions , National Institute , North America , Fischer Scientific , Rad Laboratories , South America , Middle East ,

Pharmacogenomics Market Set to Double by 2025 with 8.61% CAGR

Introduction: In the dynamic landscape of healthcare, the pharmacogenomics market has emerged as a pivotal player, bridging the gap between personalized therapy and genetic insights. With a remarkable growth trajectory, the market has captured the attention of both healthcare professionals and patients alike. This a. ....

Admera Health , Research Institutions , Abbott Laboratories , Transformative Market Journey , Chronic Diseases , Technological Advances , Pharmacogenomics Market , Generation Sequencing , Chain Reaction , From Alzheimer , End User ,